Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report.
Bang
Bo
B
Gniadecki
Robert
R
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015535:Arthritis, Psoriatic / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab